Tag: CES 2026
Top News
ABL Bio to Launch Global Phase 3 Trial of ABL111 in...
ABL Bio will begin global Phase 3 trials for its dual antibody gastric cancer treatment 'ABL111' this December after FDA discussions.
- Our Sponsors Ad -